Skip to main navigation Skip to search Skip to main content

A Phase 2, Randomized, Double-Blind, Placebo-Controlled Clinical Study to Assess the Safety and Effectiveness of Tovinontrine in Patients With Chronic Heart Failure With Preserved Ejection Fraction Cycle 2

Project: Research

Project Details

StatusActive
Effective start/end date08/13/2412/26/26

Funding

  • Cardurion Pharmaceuticals Incorporated: $234,358.50